Billy Evans, the partner of Elizabeth Holmes, who is serving an 11-year prison sentence for defrauding investors in her blood-testing company Theranos, has launched a new blood-testing startup called Haemanthus. The company aims to use artificial intelligence to analyze biological fluids for diseases. Despite assurances that this venture is distinct from Theranos, skepticism remains due to similarities in approach and technology. Holmes herself has expressed interest in continuing her work in healthcare tech from prison.
— new from The Cut
